ES2186197T3 - Procedimiento de solubilizacion de principios farmaceuticamente activos en agua y en vehiculos acuosos. - Google Patents
Procedimiento de solubilizacion de principios farmaceuticamente activos en agua y en vehiculos acuosos.Info
- Publication number
- ES2186197T3 ES2186197T3 ES98937757T ES98937757T ES2186197T3 ES 2186197 T3 ES2186197 T3 ES 2186197T3 ES 98937757 T ES98937757 T ES 98937757T ES 98937757 T ES98937757 T ES 98937757T ES 2186197 T3 ES2186197 T3 ES 2186197T3
- Authority
- ES
- Spain
- Prior art keywords
- water
- pharmaceutically active
- complex
- solubilization
- procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97RM000456A IT1294205B1 (it) | 1997-07-23 | 1997-07-23 | Procedimento per la solubilizzazione in acqua e in veicoli acquosi di sostanze farmacologicamente attive |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2186197T3 true ES2186197T3 (es) | 2003-05-01 |
Family
ID=11405192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES98937757T Expired - Lifetime ES2186197T3 (es) | 1997-07-23 | 1998-07-22 | Procedimiento de solubilizacion de principios farmaceuticamente activos en agua y en vehiculos acuosos. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6346273B1 (enExample) |
| EP (1) | EP0994727B1 (enExample) |
| JP (1) | JP2001510810A (enExample) |
| AT (1) | ATE226451T1 (enExample) |
| AU (1) | AU8645098A (enExample) |
| DE (1) | DE69808911T2 (enExample) |
| EA (1) | EA002326B1 (enExample) |
| ES (1) | ES2186197T3 (enExample) |
| IT (1) | IT1294205B1 (enExample) |
| PT (1) | PT994727E (enExample) |
| WO (1) | WO1999004823A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19845305A1 (de) * | 1998-10-01 | 2000-04-06 | Beiersdorf Ag | Verwendung von oberflächenaktiven Citronensäureestern zur Stabilisierung von Flavonen, Flavanonen bzw. Flavonoiden, synergistische Gemische aus Flavonen, Flavanonen bzw. Flavonoiden und oberflächenaktiven Substanzen sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen |
| SK2805U (sk) * | 2000-10-05 | 2001-03-12 | Unimed Pharma Spol Sro | Očná instilácia s dekongescentným účinkom |
| US6866396B2 (en) * | 2002-10-09 | 2005-03-15 | Jji Lighting Group, Inc. | Illuminating device with rotatably adjustable support |
| US20040115226A1 (en) * | 2002-12-12 | 2004-06-17 | Wenji Li | Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same |
| CA2534342C (en) * | 2003-07-29 | 2016-05-10 | V. Ravi Chandran | Amino acid prodrugs |
| US6960300B2 (en) * | 2003-09-08 | 2005-11-01 | Sami Labs Limited | Process for preparing water soluble diterpenes and their applications |
| US20050238675A1 (en) * | 2004-04-26 | 2005-10-27 | Wenjie Li | Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications |
| CA2571554A1 (en) * | 2004-06-28 | 2006-01-19 | Alza Corporation | A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device |
| US20100239629A1 (en) * | 2006-07-31 | 2010-09-23 | Isp Investments Inc. | Delivery system for delivering bioactive materials |
| US20100260691A1 (en) * | 2006-07-31 | 2010-10-14 | Narayanan Kolazi S | Aqueous compositions containing a hydrophobic material |
| EP2069363B1 (en) | 2006-09-22 | 2013-03-20 | Cipla Ltd. | Rifaximin in an amorphous form |
| US8747871B2 (en) * | 2006-09-28 | 2014-06-10 | Isp Investments Inc. | Synergistic matrix composite for making stable microemulsions of active ingredients |
| US9717584B2 (en) * | 2007-04-13 | 2017-08-01 | W. L. Gore & Associates, Inc. | Medical apparatus and method of making the same |
| US8916193B2 (en) * | 2008-12-10 | 2014-12-23 | Cipla Limited | Rifaximin complexes |
| RU2523562C1 (ru) * | 2013-05-23 | 2014-07-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения Российской Федерации (ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздрава России) | Способ получения таблеток рутина |
| US9814560B2 (en) * | 2013-12-05 | 2017-11-14 | W. L. Gore & Associates, Inc. | Tapered implantable device and methods for making such devices |
| WO2016197017A1 (en) | 2015-06-05 | 2016-12-08 | W. L. Gore & Associates, Inc. | A low bleed implantable prosthesis with a taper |
| WO2017103840A1 (en) * | 2015-12-16 | 2017-06-22 | MOHAMED ABDULLA ANZAR, Cheppattu | A water soluble 10% w/w forskolin composition and a method of synthesizing the same |
| LT3565602T (lt) | 2017-01-09 | 2021-06-25 | SciPharm S.à r.l. | Naujas būdas, skirtas vandenyje tirpaus forskolino paruošimui |
| JP6506787B2 (ja) * | 2017-03-06 | 2019-04-24 | ストローブ株式会社 | 成膜方法 |
| FI4093374T3 (en) * | 2020-01-23 | 2024-02-06 | Scipharm S A R L | Complex of 7-deacetylforskolin and PVP |
| KR20220149987A (ko) * | 2021-05-03 | 2022-11-10 | 연세대학교 산학협력단 | 안구건조증 또는 안구건조증 연관 안과 질환의 예방, 개선 또는 치료용 조성물 |
| TR2021013305A2 (tr) * | 2021-08-23 | 2023-03-21 | Tuem Ekip Ilac Anonim Sirketi | Li̇yofi̇li̇ze levosi̇mendan formülasyonlari |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4883785A (en) * | 1984-07-27 | 1989-11-28 | Chow Wing Sun | Complex of anti-fungal agent and cyclodextrin and method |
| US4900775A (en) | 1988-02-29 | 1990-02-13 | Gaf Chemicals Corporation | Solubilization of complexes of water-insoluble organic compounds by aqueous solutions of polyvinylpyrrolidone |
| WO1990010021A1 (en) * | 1989-02-24 | 1990-09-07 | Gaf Chemicals Corporation | Solubilization of indomethacin and piroxicam by a quaternized polymer |
| IL89530A0 (en) * | 1989-03-08 | 1989-09-10 | Jeffrey J Feigenbaum | Compositions containing forskolin |
| US5141961A (en) * | 1991-06-27 | 1992-08-25 | Richrdson-Vicks Inc. | Process for solubilizing difficulty soluble pharmaceutical actives |
| JPH10500982A (ja) * | 1994-05-27 | 1998-01-27 | ファーマーク、ネダーランド、ベスローテン、フェンノートシャップ | 医薬組成物 |
| KR100966245B1 (ko) * | 1997-03-12 | 2010-06-28 | 아보트 러보러터리즈 | 사이클로스포린 투여용 친수성 2원 시스템 |
-
1997
- 1997-07-23 IT IT97RM000456A patent/IT1294205B1/it active IP Right Grant
-
1998
- 1998-07-22 WO PCT/IT1998/000206 patent/WO1999004823A1/en not_active Ceased
- 1998-07-22 EP EP98937757A patent/EP0994727B1/en not_active Expired - Lifetime
- 1998-07-22 DE DE69808911T patent/DE69808911T2/de not_active Expired - Fee Related
- 1998-07-22 US US09/463,331 patent/US6346273B1/en not_active Expired - Fee Related
- 1998-07-22 EA EA200000154A patent/EA002326B1/ru not_active IP Right Cessation
- 1998-07-22 AU AU86450/98A patent/AU8645098A/en not_active Abandoned
- 1998-07-22 AT AT98937757T patent/ATE226451T1/de not_active IP Right Cessation
- 1998-07-22 PT PT98937757T patent/PT994727E/pt unknown
- 1998-07-22 JP JP2000503874A patent/JP2001510810A/ja active Pending
- 1998-07-22 ES ES98937757T patent/ES2186197T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US6346273B1 (en) | 2002-02-12 |
| ATE226451T1 (de) | 2002-11-15 |
| WO1999004823A1 (en) | 1999-02-04 |
| ITRM970456A1 (it) | 1999-01-23 |
| DE69808911T2 (de) | 2003-06-12 |
| AU8645098A (en) | 1999-02-16 |
| EP0994727B1 (en) | 2002-10-23 |
| JP2001510810A (ja) | 2001-08-07 |
| ITRM970456A0 (enExample) | 1997-07-23 |
| IT1294205B1 (it) | 1999-03-24 |
| EA200000154A1 (ru) | 2000-10-30 |
| EP0994727A1 (en) | 2000-04-26 |
| DE69808911D1 (de) | 2002-11-28 |
| PT994727E (pt) | 2003-03-31 |
| EA002326B1 (ru) | 2002-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1294205B1 (it) | Procedimento per la solubilizzazione in acqua e in veicoli acquosi di sostanze farmacologicamente attive | |
| CY1114631T1 (el) | Φαρμακοτεχνικες μορφες εχινοκανδινης που περιεχουν επιφανειοδραστικα που σχηματιζουν μικκυλιο | |
| MA26922A1 (fr) | Procede de preparation d'une composition | |
| FI970995A0 (fi) | Farmaseuttisia yhdisteitä | |
| ES2081531T3 (es) | Composiciones farmaceuticas que contienen rifaximina para el tratamiento de infecciones vaginales. | |
| ES2178268T3 (es) | Formulaciones de liberacion controlada. | |
| CO5680109A1 (es) | Compuestos para el tratamiento de la disfuncion sexual femenina | |
| DE60023465D1 (de) | Pharmazeutische formulierungen mit verbesserter löslichkeit in wasser | |
| ES2231819T3 (es) | Particulas de lipido-acido nucleico preparadas a traves de un intermedio complejo de lipido-acido nucleico hidrofobo y uso para transferir genes. | |
| DK1158959T3 (da) | Sammensætninger og fremgangsmåder til forbedret indgift af hydrofobe terapeutiske midler | |
| PE20000272A1 (es) | Formulaciones farmaceuticas de epotilonas | |
| BR0112311A (pt) | Compostos e composições para liberar agentes ativos, forma de dosagem unitária, método para preparar ditas composições e seu uso | |
| BR0111016A (pt) | Composições farmacêuticas de liberação sustentada para a administração parenteral de compostos hidrófilos biologicamente ativos | |
| NO20025629L (no) | Formulering | |
| ES2145158T3 (es) | Nueva formulacion de emulsion. | |
| GB2380675A (en) | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | |
| DE69924004D1 (de) | Verabreichungssystem für wasserunlösliche arzneistoffe | |
| NO20014101L (no) | Stabilisert oral farmasöytisk blanding inneholdende iodid og iodat og fremgangsmåte | |
| CU22836A3 (es) | Sistema de gel de nimesulida para uso tópico | |
| PE20040471A1 (es) | Formulaciones de liberacion prolongada en forma de suspension | |
| AR037138A1 (es) | Formulacion farmaceutica, uso de fulvestrant en la preparacion de la misma y jeringa o vial esteriles que comprenden dicha formulacion | |
| AR024959A1 (es) | Una composicion farmaceutica liquida basada en paracetamol | |
| ATE289276T1 (de) | Kanister enthaltend eine wirkstoff-formulierung mit fluorkohlenwasserstoff als treibmittel | |
| DK1061948T3 (da) | Præparat til vedvarende frigivelse af et fysiologisk aktivt polypeptid samt fremstilling deraf | |
| BR0012735A (pt) | Preparação solida, e, processo para produzir preparações |